Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
corporation tags : Vaccine save search
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Published: 2024-03-26 (Crawled : 06:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.72%
H: 0.4%
C: -1.75%
candidate vaccine valneva trial
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
Published: 2024-03-19 (Crawled : 13:30) - biospace.com/
CVM | $1.46 -0.68% 0.0% 76K
|
Health Technology
|
| O: 0.0%
H: 1.46%
C: -0.98%
vaccine treat immunology
Veterinary Vaccine Global Market Forecast Report: A $19.86 Billion Market by 2033, Registering 7.3% CAGR During 2023-2033
Published: 2024-03-18 (Crawled : 19:00) - prnewswire.com
ELAN | $13.31 -1.11% 0.0% 3.8M
|
Process Industries
|
| O: -0.63%
H: 0.92%
C: 0.0%
PAHC | $12.575 -7.61% -8.23% 110K
|
Health Technology
|
| O: -0.16%
H: 0.8%
C: -0.08%
veterinary vaccine global market
Uvax Bio to give a Preclinical Development Update on its HIV-1 Vaccine at the World Vaccine Congress – West Coast 2023
Published: 2023-11-28 (Crawled : 16:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: -2.14%
west vaccine congress world update preclinical
Global HBV Vaccine Market Set to Reach $2.47 Billion by 2023, Driven by Rising HBV Cases Among Infants
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
vaccine reach global set market
Vaccine Adjuvants Market worth $1.2 billion | MarketsandMarkets
Published: 2023-09-04 (Crawled : 15:00) - prnewswire.com
PAHC | $12.575 -7.61% -8.23% 110K
|
Health Technology
| Email alert
Add to watchlist
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
| Email alert
Add to watchlist
vaccine market
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.03%
H: 0.37%
C: 0.18%
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.08%
H: 1.31%
C: 0.77%
vaccine expected cancer global
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001
Published: 2023-03-02 (Crawled : 08:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.88%
H: 1.29%
C: 0.79%
covid-19 valneva vaccine vla2001
Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
Published: 2023-02-28 (Crawled : 16:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.0%
H: 1.25%
C: -0.58%
hepatitis vaccine authorization
PDS Biotech Announces Publication of Preclinical Infectimune™ Based Vaccine Studies Demonstrating Effective Protection Against Viral Infection in Peer-Reviewed Journal, Viruses
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: 2.43%
H: 2.61%
C: -2.73%
preclinical biotech vaccine publication infection
Global Hepatitis B Virus (HBV) Vaccine Market Report 2023-2027 Featuring GSK, Merck, Sanofi, Dynavax, LG Chem, VBI Vaccines and Meiji Group Among Others
Published: 2023-01-31 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.7%
H: 2.08%
C: 0.88%
hepatitis global report vaccine virus group market
Aeolian Biotech Corp. Formed to Create an Improved Pneumococcal Vaccine with Experienced Vaccine Development Leadership Team
Published: 2023-01-30 (Crawled : 00:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.0%
H: 0.79%
C: -0.55%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: -3.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: 0.0%
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -2.81%
biotech vaccine pneumococcal
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
Published: 2023-01-16 (Crawled : 01:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
| Email alert
Add to watchlist
covid-19 clover vaccine commercial
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine
Published: 2022-12-30 (Crawled : 18:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -1.31%
H: 1.24%
C: 1.14%
covid-19 valneva vaccine
Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone Everest Medicines announced that the company has achieved the preclinical proof-of-...
Published: 2022-12-15 (Crawled : 08:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
PRTA 4 | $20.59 0.15% 0.15% 340K
|
Health Technology
|
| O: 0.97%
H: 7.04%
C: -0.02%
MTP | $0.4703 -70.79% -73.69% 0
|
Health Technology
|
| O: -4.03%
H: 2.0%
C: -15.78%
preclinical vaccine program mrna milestone
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
Published: 2022-11-30 (Crawled : 11:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.51%
H: 4.02%
C: 3.94%
candidate vaccine sars-cov-2 study
Vaccine Cold Chain Logistics Market Expected to Reach US$ 4.90 Billion by 2030 - Growing Beyond COVID-19 Application
Published: 2022-11-23 (Crawled : 14:20) - prnewswire.com
FDX 4 | $266.07 -2.09% 0.0% 1.7M
|
Transportation
|
| O: 0.08%
H: 0.61%
C: 0.31%
covid-19 growing vaccine application expected market
PDS Biotech Executives to Present an Overview of Oncology and Infectious Disease Programs at the World Vaccine & Immunotherapy Congress
Published: 2022-11-21 (Crawled : 13:00) - globenewswire.com
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: 0.12%
H: 5.43%
C: -4.85%
disease immunotherapy biotech vaccine
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 14:20) - biospace.com/
VBIV | $0.5893 -3.16% -3.26% 130K
|
Health Technology
|
| O: -0.73%
H: 11.01%
C: -1.16%
financial update results vaccine
The Worldwide Vaccine Adjuvants Industry is Projected to Reach $16 Billion by 2027
Published: 2022-10-17 (Crawled : 19:00) - prnewswire.com
PAHC | $12.575 -7.61% -8.23% 110K
|
Health Technology
|
| O: 1.93%
H: 1.12%
C: -0.35%
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
|
| O: 1.87%
H: 2.2%
C: -0.37%
vaccine
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.